Relationship Between S100 Protein Expression and Grading Meningioma
DOI:
10.29303/jppipa.v11i7.11529Published:
2025-07-29Downloads
Abstract
Meningioma is the most common type of benign brain tumor in adults and mostly originates from the meningeal layer of the brain and spinal cord. The prevalence of meningioma in the world is estimated to be about 24-30% of intracranial primary brain tumors. This tumor is classified into three groups based on grade, grade I (benign), grade II (atypical), and grade III (anaplastic). The S100 protein is not specific to meningiomas but some studies have shown that the expression of S100 protein is stronger in grade I meningiomas than in grade II and III meningiomas. Based on these findings, the authors are interested in analyzing whether there is a relationship between S100 expression and meningioma grading. The determination of S100 protein expression is very necessary as a reference in determining the prognosis and selection of the best therapy for patients. This research was carried out in the period from January 2021 to December 2021. 9 samples were included in this study according to the inclusion and exclusion criteria. The data was analyzed using SPSS version 26. The results of this study: A normality test was carried out with the Shapiro Wilk test and a value of p=0.34 (CI 95%) was obtained using Spearman analysis.
Keywords:
Grading Meningioma S100 proteinReferences
Allgöwer, C., Kretz, A.-L., Von Karstedt, S., Wittau, M., Henne-Bruns, D., & Lemke, J. (2020). Friend or Foe: S100 Proteins in Cancer. Cancers, 12(8), 2037. https://doi.org/10.3390/cancers12082037
Ammendola, S., Bariani, E., Eccher, A., Capitanio, A., Ghimenton, C., Pantanowitz, L., Parwani, A., Girolami, I., Scarpa, A., & Barresi, V. (2021). The histopathological diagnosis of atypical meningioma: Glass slide versus whole slide imaging for grading assessment. Virchows Archiv, 478(4), 747–756. https://doi.org/10.1007/s00428-020-02988-1
Aung, T. M., Ngamjarus, C., Proungvitaya, T., Saengboonmee, C., & Proungvitaya, S. (2024). Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis. PLOS ONE, 19(5), e0303337. https://doi.org/10.1371/journal.pone.0303337
Azamat, S., Buz-Yalug, B., Dindar, S. S., Yilmaz Tan, K., Ozcan, A., Can, O., Ersen Danyeli, A., Pamir, M. N., Dincer, A., Ozduman, K., & Ozturk-Isik, E. (2024). Susceptibility-Weighted MRI for Predicting NF-2 Mutations and S100 Protein Expression in Meningiomas. Diagnostics, 14(7), 748. https://doi.org/10.3390/diagnostics14070748
Bassiouny, M., Badour, N., Omran, A., & Osama, H. (2012). Histopathological and immunohistochemical characteristics of acquired cholesteatoma in children and adults. Egyptian Journal of Ear, Nose, Throat and Allied Sciences, 13(1), 7–12. https://doi.org/10.1016/j.ejenta.2012.02.007
Behling, F., Fodi, C., Gepfner-Tuma, I., Kaltenbach, K., Renovanz, M., Paulsen, F., Skardelly, M., Honegger, J., Tatagiba, M., Schittenhelm, J., & Tabatabai, G. (2021). H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort. Neuro-Oncology, 23(8), 1273–1281. https://doi.org/10.1093/neuonc/noaa303
Behling, F., Hempel, J.-M., & Schittenhelm, J. (2021). Brain Invasion in Meningioma—A Prognostic Potential Worth Exploring. Cancers, 13(13), 3259. https://doi.org/10.3390/cancers13133259
Brastianos, P. K., Galanis, E., Butowski, N., Chan, J. W., Dunn, I. F., Goldbrunner, R., Herold-Mende, C., Ippen, F. M., Mawrin, C., McDermott, M. W., Sloan, A., Snyder, J., Tabatabai, G., Tatagiba, M., Tonn, J. C., Wen, P. Y., Aldape, K., Nassiri, F., Zadeh, G., & Workewych, A. M. (2019). Advances in multidisciplinary therapy for meningiomas. Neuro-Oncology, 21, I18–I31. https://doi.org/10.1093/neuonc/noy136
Dunn, J., Ferluga, S., Sharma, V., Futschik, M., Hilton, D. A., Adams, C. L., Lasonder, E., & Hanemann, C. O. (2019). Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism. EBioMedicine, 40, 77–91. https://doi.org/10.1016/j.ebiom.2018.12.048
Franca, R. A., Della Monica, R., Corvino, S., Chiariotti, L., & Del Basso De Caro, M. (2023). WHO grade and pathological markers of meningiomas: Clinical and prognostic role. Pathology - Research and Practice, 243, 154340. https://doi.org/10.1016/j.prp.2023.154340
Halabi, R., Dakroub, F., Haider, M. Z., Patel, S., Amhaz, N. A., Reslan, M. A., Eid, A. H., Mechref, Y., Darwiche, N., Kobeissy, F., Omeis, I., & Shaito, A. A. (2023). Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis. Cancers, 15(22), 5339. https://doi.org/10.3390/cancers15225339
Huntoon, K., Toland, A. M. S., & Dahiya, S. (2020). Meningioma: A Review of Clinicopathological and Molecular Aspects. Frontiers in Oncology, 10. https://doi.org/10.3389/fonc.2020.579599
Iwadate, R., Inoue, J., Tsuda, H., Takano, M., Furuya, K., Hirasawa, A., Aoki, D., & Inazawa, J. (2015). High Expression of p62 Protein Is Associated with Poor Prognosis and Aggressive Phenotypes in Endometrial Cancer. The American Journal of Pathology, 185(9), 2523–2533. https://doi.org/10.1016/j.ajpath.2015.05.008
Kalamarides, M., & Peyre, M. (2020). An overview of meningiomas. Meningiomas: Comprehensive Strategies for Management, 14(June), 3–10. https://doi.org/10.1007/978-3-030-59558-6_1
Lee, J. H. (Ed.). (2009). Meningiomas: Diagnosis, Treatment, and Outcome. American Journal of Neuroradiology, 30(10), E157–E157. https://doi.org/10.3174/ajnr.a1775
Li, X., Miao, Y., Han, L., Dong, J., Guo, Y., Shang, Y., Xie, L., Song, Q., & Liu, A. (2019). Meningioma grading using conventional MRI histogram analysis based on 3D tumor measurement. European Journal of Radiology, 110, 45–53. https://doi.org/10.1016/j.ejrad.2018.11.016
Liu, Y., Cui, J., Tang, Y. L., Huang, L., Zhou, C. Y., & Xu, J. X. (2018). Prognostic Roles of mRNA Expression of S100 in Non-Small-Cell Lung Cancer. BioMed Research International, 2018. https://doi.org/10.1155/2018/9815806
Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., Hawkins, C., Ng, H. K., Pfister, S. M., Reifenberger, G., Soffietti, R., Von Deimling, A., & Ellison, D. W. (2021). The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro-Oncology, 23(8), 1231–1251. https://doi.org/10.1093/neuonc/noab106
Maggio, I., Franceschi, E., Tosoni, A., Nunno, V. D., Gatto, L., Lodi, R., & Brandes, A. A. (2021). Meningioma: Not always a benign tumor. A review of advances in the treatment of meningiomas. CNS Oncology, 10(2). https://doi.org/10.2217/cns-2021-0003
Meuten, D. J., Moore, F. M., Donovan, T. A., Bertram, C. A., Klopfleisch, R., Foster, R. A., Smedley, R. C., Dark, M. J., Milovancev, M., Stromberg, P., Williams, B. H., Aubreville, M., Avallone, G., Bolfa, P., Cullen, J., Dennis, M. M., Goldschmidt, M., Luong, R., Miller, A. D., & Whitley, D. (2021). International Guidelines for Veterinary Tumor Pathology: A Call to Action. Veterinary Pathology, 58(5), 766–794. https://doi.org/10.1177/03009858211013712
Mizrachi, M., Hartley, B., Saleem, S., Hintz, E., Ziemba, Y., Li, J., Goenka, A., & Schulder, M. (2024). Ki-67 index as a predictive marker of meningioma recurrence following surgical resection. Journal of Clinical Neuroscience, 124, 15–19. https://doi.org/10.1016/j.jocn.2024.04.015
Nassiri, F., Liu, J., Patil, V., Mamatjan, Y., Wang, J. Z., Hugh-White, R., Macklin, A. M., Khan, S., Singh, O., Karimi, S., Corona, R. I., Liu, L. Y., Chen, C. Y., Chakravarthy, A., Wei, Q., Mehani, B., Suppiah, S., Gao, A., Workewych, A. M., & Zadeh, G. (2021). A clinically applicable integrative molecular classification of meningiomas. Nature, 597(7874), 119–125. https://doi.org/10.1038/s41586-021-03850-3
Ogasawara, C., Philbrick, B. D., & Adamson, D. C. (2021). Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions. Biomedicines, 9(3), 319. https://doi.org/10.3390/biomedicines9030319
Poulen, G., Vignes, J.-R., Le Corre, M., Loiseau, H., & Bauchet, L. (2020). WHO grade II meningioma: Epidemiology, survival and contribution of postoperative radiotherapy in a multicenter cohort of 88 patients. Neurochirurgie, 66(2), 73–79. https://doi.org/10.1016/j.neuchi.2019.12.008
Putri, T. A. K., Prihatin, L. M., & Priyanto, B. (2023). Meningioma: A Literature Review. Jurnal Biologi Tropis, 23(1), 364–370. https://doi.org/10.29303/jbt.v23i1.5784
Raso, M. G., Barrientos Toro, E., Evans, K., Rizvi, Y., Lazcano, R., Akcakanat, A., Sini, P., Trapani, F., Madlener, E. J., Waldmeier, L., Lazar, A., & Meric-Bernstam, F. (2024). Heterogeneous Profile of ROR1 Protein Expression across Tumor Types. Cancers, 16(10), 1874. https://doi.org/10.3390/cancers16101874
Riehl, A., Németh, J., Angel, P., & Hess, J. (2009). The receptor RAGE: Bridging inflammation and cancer. Cell Communication and Signaling, 7(1). https://doi.org/10.1186/1478-811x-7-12
Sefo, H., Rovčanin, B., Jesenković, D. A., Džeko, M., Avdić, A., Ahmetspahić, A., Omerhodžić, I., Hadžić, E., & Konjo, H. (2024). Clinical and radiologic features in patients with the WHO grade I and II meningiomas. Journal of Health Sciences, 14(1), 51–55. https://doi.org/10.17532/jhs.2024.2564
Sheloukhova, L., & Watanabe, H. (2024). Evolution of glial cells: A non-bilaterian perspective. Neural Development, 19(1). https://doi.org/10.1186/s13064-024-00184-4
Silva, L. C. D., Cirino, M. L. D. A., Novais, P. C., Rios, Á. F. L., Celani, M. V. B., Lellis, J. R., Turra, L. P., Tazima, M. D. F. G. S., Peria, F. M., Junior, C. G. C., & Tirapelli, D. P. D. C. (2025). The Role of Mir-34a and Mir-145 as Potential Biomarkers of Meningioma Recurrence. Advances in Bioscience and Biotechnology, 16(02), 13–29. https://doi.org/10.4236/abb.2025.162002
Sinha, P., Okoro, C., Foell, D., Freeze, H. H., Ostrand-Rosenberg, S., & Srikrishna, G. (2008a). Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells. The Journal of Immunology, 181(7), 4666–4675. https://doi.org/10.4049/jimmunol.181.7.4666
Sinha, P., Okoro, C., Foell, D., Freeze, H. H., Ostrand-Rosenberg, S., & Srikrishna, G. (2008b). Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells. The Journal of Immunology, 181(7), 4666–4675. https://doi.org/10.4049/jimmunol.181.7.4666
Sobhy, N., El-Mulla, K., Elmessiry, M., & El-Gendi, S. (2011). Histopathological and immunohistochemical study of the wall of spermatic veins and its potential role in the development of varicocele testis. Alexandria Journal of Medicine, 47(3), 209–215. https://doi.org/10.1016/j.ajme.2011.07.002
Trivedi, T., Bhalala, N., Dialani, K., & Trivedi, P. (2024). Protein expression of CD44 in patients with meningioma tumors: Association with clinicopathological parameters and survival. Journal of the Egyptian National Cancer Institute, 36(1). https://doi.org/10.1186/s43046-024-00249-9
Ülgen, E., Bektaşoğlu, P. K., Sav, M. A., Can, Ö., Danyeli, A. E., Hızal, D. B., Pamir, M. N., & Özduman, K. (2019). Meningiomas Display a Specific Immunoexpression Pattern in a Rostrocaudal Gradient: An Analysis of 366 Patients. World Neurosurgery, 123, e520–e535. https://doi.org/10.1016/j.wneu.2018.11.201
Wang, D., Liu, G., Wu, B., Chen, L., Zeng, L., & Pan, Y. (2018). Clinical Significance of Elevated S100A8 Expression in Breast Cancer Patients. Frontiers in Oncology, 8. https://doi.org/10.3389/fonc.2018.00496
Yuen, C. A., Zheng, M., Saint-Germain, M. A., & Kamson, D. O. (2025). Meningioma: Novel Diagnostic and Therapeutic Approaches. Biomedicines, 13(3), 659. https://doi.org/10.3390/biomedicines13030659
Zhang, S., Wang, Z., Liu, W., Lei, R., Shan, J., Li, L., & Wang, X. (2017). Distinct prognostic values of S100 mRNA expression in breast cancer. Scientific Reports, 7(1). https://doi.org/10.1038/srep39786
Zhou, J., Butler, E. E., & Rose, J. (2017). Neurologic Correlates of Gait Abnormalities in Cerebral Palsy: Implications for Treatment. Frontiers in Human Neuroscience, 11. https://doi.org/10.3389/fnhum.2017.00103
Zuo, X., Li, B., Zhu, C., Yan, Z.-W., Li, M., Wang, X., & Zhang, Y.-J. (2019). Stoichiogenomics reveal oxygen usage bias, key proteins and pathways associated with stomach cancer. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-019-47533-6
License
Copyright (c) 2025 Lale Maulin Prihatina; Rohadi, Bambang Priyanto; Decky Aditya Zulkarnaen, Abdul Syukur
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Jurnal Penelitian Pendidikan IPA, agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Jurnal Penelitian Pendidikan IPA.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
